[Endomyocardial disease as the first manifestation of hypereosinophilic syndrome]

Kardiol Pol. 2010 Apr;68(4):440-5.
[Article in Polish]

Abstract

A case of hypereosinophilic syndrome (HES) initially manifesting as endomyocardial disease in a 21-year-old man is presented. The diagnosis of HES was made according to the Chusid's criteria. Myeloproliferative disorders were excluded and corticosteroid therapy with prednisone at a dose of 1 mg/kg/d was started immediately. After 30 days of continuous corticotherapy the patient recovered completely. His blood eosinophil count decreased from 8740 cells/microL (48.7%) to 30 cells/microL (0.3%). Then, prednisone was discontinued gradually. During 18-month follow-up the patient was free from cardiovascular symptoms and his complete blood count was normal. We also present the current state of knowledge on the cardiovascular complications of hypereosinophilic syndrome.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Diagnosis, Differential
  • Endomyocardial Fibrosis / complications
  • Endomyocardial Fibrosis / pathology*
  • Glucocorticoids / therapeutic use
  • Humans
  • Hypereosinophilic Syndrome / complications
  • Hypereosinophilic Syndrome / diagnosis*
  • Hypereosinophilic Syndrome / drug therapy
  • Male
  • Myocardium / pathology
  • Prednisone / therapeutic use

Substances

  • Glucocorticoids
  • Prednisone